Research Grants

  • Biology of neuronal connexins – regulation of cellular transport by proteasome and endosome blockers in the excitotoxicity-induced neurodegeneration of retinal ganglion cells, SUM research grant (2022-2023), Principal Investigator Adrian Smedowski MD PhD
  • Tolerance and pharmacokinetics of MF-438 as a novel anti-inflammatory component in eye drops containing prostaglandin analogues for the glaucoma treatment, Doktorat Wdrożeniowy (2022-2026), PhD student Małgorzata Kłeczek-Gabryś MD, Supervisor Adrian Smedowski MD PhD
  • Oral L-tyrosine supplementation to support the retinal function in axial myopia, Doktorat Wdrożeniowy (2022-2026), PhD student Bartosz Machna Msc, Supervisor Adrian Smedowski MD PhD
  • The role of Brain Derived Neurotrophic Factor (BDNF) and electrical synapses in the neuroprotective activity of Escitalopram in a mouse model of retinal ischemia, NCN Preludium BIS (2022-2026), Principal Investigator - Adrian Smedowski MD PhD
  • Interaction between selective estrogen receptor modulators (SERMs) and FasR/FasL pathway in the retina of ovariectomized rats under ischemic conditions, NCN Preludium (2022-2025), Principal Investigator - Piotr Rodak MD, Supervisor - Adrian Smedowski MD PhD
  • CRISPR/Cas9 for inhibiting transthyretin (TTR) expression in the eye with TTR-amyloidosis, Umeå University Sweden collaborative grant (2022-2024), Principal Investigator in SUM - Adrian Smedowski MD PhD
  • Screening for new therapeutic targets in inherited retinal diseases based on protein-protein interactions analysis, NCN POLS (2021-2023), Principal Investigator – Xiaonan Liu PhD, Supervisor - Adrian Smedowski MD PhD
  • Development of an innovative experimental gene therapy for glaucoma treatment – the role of RNA-binding proteins, NCN SONATA (2018-2021), Principal Investigator - Adrian Smedowski MD PhD
  • The influence of ketogenic diet and MCT supplementation on neurogenesis, neuroinflammation and blood brain barrier permeability in rats with western diet-induced obesity, Nutricia Foundation Grant no RG 1/2017, Principal Investigator – Arkadiusz Liskiewicz PhD 
  • Potential mechanism of chronic adnexa inflammation induced by preservative-free prostaglandin analogue eyedrops, SANTEN (2018-2019), Principal Investigator - Adrian Smedowski MD PhD
  • The role of the EMMPRIN protein in the rat subarachnoid hemorrhage model and in the mechanisms of the neuroprotective action of minocycline, NCN Preludium (2014-2018), Principal Investigator – Daria Gendosz-de Carillo, Supervisor – Joanna Lewin-Kowalik MD PhD
  • Schwann cells mediated neuroprotection of retinal ganglion cells in the animal model of glaucoma, SUM (2012-2015), Principal Investigator - Adrian Smedowski MD PhD
  • Tolerability of preservative-free prostaglandin analogue eyedrops, SANTEN (2013-2015), Principal Investigator - Adrian Smedowski MD PhD